Showing results (91-100 of 287) with videos related to
Sort By:
Pageof 29
The Cochrane Database of Systematic Reviews|July 8, 2011
Sublingual immunotherapy for treating allergic conjunctivitisMoises A Calderon, Martin Penagos, Aziz Sheikh, et al.Current Opinion in Allergy and Clinical Immunology|July 2, 2022
Severe asthma and personalized approach in the choice of biologicDanilo Di Bona, Federico Spataro, Palma Carlucci, et al.Asia Pacific Allergy|June 30, 2023
Real-world data: A relevant component in the framework of scientific evidenceGiorgio W Canonica, Lorenzo Del Moro, Giovanni Costanzo, et al.Therapeutic Advances in Respiratory Disease|January 19, 2022
Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolutionFulvio Braido, Angelo G Corsico, Davide Paleari, et al.COPD|May 3, 2014
Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteinePierachille Santus, Angelo Corsico, Paolo Solidoro, et al.Patient Related Outcome Measures|August 28, 2018
Impact of reslizumab on outcomes of severe asthmatic patients: current perspectivesAlicia Padilla Galo, Marina Labor, Angelica Tiotiu, et al.European Journal of Internal Medicine|August 1, 2026
Particle engineering, aerosol physics, and pulmonary deposition of single-inhaler triple ICS/LABA/LAMA therapies in obstructive airway diseasesClaudio Sorino, Johann Christian Virchow, Antonio Spanevello, et al.Respiratory Medicine|September 5, 2013
Long-acting bronchodilators improve health related quality of life in patients with COPDFulvio Braido, Ilaria Baiardini, Mario Cazzola, et al.Expert Review of Respiratory Medicine|January 13, 2015
The relationship between allergen immunotherapy and omalizumab for treating asthmaFulvio Braido, Angelo Corsico, Anthi Rogkakou, et al.Expert Review of Clinical Immunology|May 19, 2010
Targeted therapy for allergic asthma: predicting and evaluating response to omalizumabFrancesco Tarantini, Fulvio Braido, Ilaria Baiardini, et al.Pageof 29